P043 Aberrant immunophenotype of blasts in low and intermediate-1 risk myelodysplastic syndromes predicts response to growth factor treatment. A prospective clinical phase II study

Saved in:
Bibliographic Details
Published in:Leukemia research 2009-05, Vol.33, p.S83-S83
Main Authors: Westers, T, Alhan, C, Van der Vorst, M, Chamuleau, M, Eeltink, C, Ossenkoppele, G, van de Loosdrecht, A
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0145-2126
1873-5835
DOI:10.1016/S0145-2126(09)70123-7